Der DOW JONES gewinnt heute 265,89 Zähler oder 3,19% auf 8607,52 Punkte
Die Hightechs des Nasdaq Composite gewinnen 49,34 Zähler oder 3,69% auf 1384,85 Punkte.
Meistgehandelte Aktie
Der NASDAQ 100 gewinnt 43,50 Zähler oder 4,42% auf 1027,86Punkte
besser zeigte sich der Amex Interactiv Internet Index (IIX) , er gewinnt aktuell 3,61 Zähler bzw 4,35 Prozent auf 86,60 Punkte .
Der PHLX Semiconductor Sector (SOX) gewinnt 19,32 Zähler oder 6,68% auf 308,56 Punkte
Der Amex Biotech Index (BTK) gewinnt 10,28 Zähler bzw. 3,04% auf 348,50Punkte
Der S&P 500 (SPX) gewinnt 29,21 Zähler oder 3,32% auf 909,03Punkte
***
EU/$ >> 1,036 ***
AFTER THE CLOSE
Home Depot guides year lower (HD) 24.88 +0.86: Company guides down Y03 (Jan), seeing EPS of $1.53-$1.55 vs Multex estimate of $1.57; cites slowing sales during the month of December.
Synopsys names new CFO (SNPS) 46.92 +0.77: Announces the appointment of Steven Shevick as senior vice president of finance and CFO; he replaces outgoing CFO Brad Henske, who is leaving the company to pursue other career opportunities see INTU comment directly preceding.
Intuit names new CFO (INTU) 47.30 +0.38: Company announces the hiring of Robert (Brad) Henske as senior vice president and CFO; Henske was formerly CFO for Synopsys -- Henske replaces former CFO Greg Santora, who announced his retirement in August 2002.
Advent Software updates guidance (ADVS) 13.64 +0.01: Co expects to generate total revenues of about $36 million for the quarter ended December 31, 2002, or "approximately five percent below previous expectations" -- Multex consensus estimate is for revs of $37.9 mln.
Amerigroup moves to NYSE tomorrow (AMGP) 30.95 +0.64: Shares will shift from the Nasdaq National Market to the New York Stock Exchange on Jan. 3 -- ticker symbol will be AGP.
Forest Labs to exceed Q3 estimates (FRX) 100.00 +1.78: Announces that fiscal Q3 EPS will exceed the current First Call consensus est of $0.77 by at least 15% (about $0.89), primarily due to strong net sales volume which will be about $585 mln (consensus is $551.6 mln); sales of its antidepressant Celexa should approximate $370 mln in the qtr, and sales of its antidepressant Lexapro should approximate $80 mln.
Starbucks announces 7% December same store sales growth (SBUX) 21.19 +0.81: Reports consolidated net revenues of $418 million for the five-week period ended December 29, 2002, an increase of 22% from consolidated net revenues of $343 million for the year ago period; on a comparable store sales basis (stores open for at least 13 months), sales at company-operated stores increased 7% for the same five weeks.
Vertex Pharm restructures agreement with Eli Lilly (VRTX) 16.36 +0.51: Announces that it has restructured its agreement with LLY and that VRTX will lead development and commercialization of VX-950, an oral hepatitis C viral protease inhibitor; VRTX plans to begin clinical testing of VX-950 in 2H03; the mutual decision to restructure the agreement is a result of a reprioritization of LLY's research portfolio and VRTX's desire to focus on specialty pharmaceutical markets and retain greater downstream rights to its own compounds.
Coinstar CFO resigns (CSTR) 22.86 +0.21: CFO Ms. Renihan intends to continue her day-to-day duties through the Company's fourth quarter earnings release and conference call to investors scheduled on February 6, 2003. Coinstar will immediately begin the search for a new Chief Financial Officer.
----------------------------------
Nachbörsliche WINNER+LOSER:
Regulärer Handel +After Hours- Top 100
____________________________________________
Nasdaq 100 Future
Nasdaq 100 After Hours Indicator
_____________________________________________
_____________________________________________
KURSLISTE in €
DAX ------------------------------
NEMAX 50
DOW JONES 30 ------------
NASDAQ 100
US-STOCKS -------------------
MDAX
--------------------------------------------------------------
NACHBÖRSLICHE QUARTALSBERICHTE
EARNINGS KALENDER
WIRTSCHAFTSDATEN -VORSCHAU
FED- KALENDER
UP- and DOWNGRADES